Prostate Cancer
Commentary Prostate Cancer Genetics: Ready for Clinical Use?

Prostate Cancer Genetics: Ready for Clinical Use?

For decades, prostate cancer risk (PCa) stratification was based primarily on the architectural pattern of the tumor.

Prostate Cancer Videos

Latest Prostate Cancer News

Prostate Cancer-Obesity Link Stronger in Blacks

Prostate Cancer-Obesity Link Stronger in Blacks

Obesity is associated with greater risk of PCa among African-American men compared to non-Hispanic white men.

Enzalutamide Improves Quality of Life in Chemo-Naive PCa Patients

Enzalutamide Improves Quality of Life in Chemo-Naive PCa Patients

Enzalutamide improves health-related quality of life (HRQoL) in chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC).

Aspirin Use Does Not Improve Prostate Cancer Mortality

Aspirin Use Does Not Improve Prostate Cancer Mortality

Increased risks of mortality restricted to aspirin use after the diagnosis of prostate cancer.

Repeat Prostate Biopsies Find Significant Cancers

Repeat Prostate Biopsies Find Significant Cancers

Increased likelihood of prostate cancer seen with fourth repeat biopsy, men.

Prostate Cancer Blood Test May Avert Biopsies

Prostate Cancer Blood Test May Avert Biopsies

The Prostate Health Index improves detection of clinically significant prostate cancer.

Time to PCa Metastasis Affects Overall Survival

Time to PCa Metastasis Affects Overall Survival

Median time to death was shortest in men with metastatic disease at diagnosis.

PCa Recurrence Not Linked to Metabolic Syndrome

PCa Recurrence Not Linked to Metabolic Syndrome

High LDL cholesterol and high blood glucose, however, did increase the risk of PSA relapse.

Fish Oil Might Reduce Chemo's Effectiveness

Fish Oil Might Reduce Chemo's Effectiveness

Research raises concern about the simultaneous use of chemotherapy and fish oil.

Androgen Deprivation Therapy Impairs Physical Function

Androgen Deprivation Therapy Impairs Physical Function

Physical side effects seen over first 12 months of androgen deprivation therapy (ADT) persisted or worsened over 3 years of follow-up.

Intermediate-Risk Prostate Cancer Varies in Prognosis

Intermediate-Risk Prostate Cancer Varies in Prognosis

Researchers conclude that intermediate-risk PCa be stratified into favorable or unfavorable risk subgroups.

PSA Rising While on Abiraterone? Taking It with Food May Help

PSA Rising While on Abiraterone? Taking It with Food May Help

In a small study of mCRPC patients, the median time on therapy increased by nearly 100 days and PSA declined in some subjects.

Preoperative MRI May Benefit Some Prostate Surgery Patients

Preoperative MRI May Benefit Some Prostate Surgery Patients

Imaging was associated with a lower risk of positive surgical margins in men with cT1 prostate tumors, but not in other subgroups.

Cause of Post-RP Death in High-Risk PCa Patients Linked to Age

Cause of Post-RP Death in High-Risk PCa Patients Linked to Age

Within 10 years of surgery, men younger than 60 years are more likely to die from prostate cancer than from other causes.